ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+32.23%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
Cap. Flow
+$2.12M
Cap. Flow %
0.72%
Top 10 Hldgs %
98%
Holding
17
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

1
CALC icon
CalciMedica
CALC
$2.17M

Top Sells

1
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$51.2K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$188M 63.5% 6,068,125 – –
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.41B
$24.4M 8.26% 1,025,000 – –
VRNA
3
Verona Pharma
VRNA
$9.16B
$17.9M 6.07% 1,115,352 – –
ELEV
4
DELISTED
Elevation Oncology
ELEV
$14.5M 4.92% 2,834,910 – –
BMEA icon
5
Biomea Fusion
BMEA
$116M
$11.9M 4.04% 798,757 – –
GLUE icon
6
Monte Rosa Therapeutics
GLUE
$296M
$10.4M 3.51% 1,472,331 – –
NUVB icon
7
Nuvation Bio
NUVB
$1.02B
$9.25M 3.13% 2,541,009 – –
CMPS
8
Compass Pathways
CMPS
$424M
$8.02M 2.72% 964,500 – –
PSTX
9
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$3.33M 1.13% 1,043,267 – –
CALC icon
10
CalciMedica
CALC
$37.7M
$2.17M 0.73% +521,114 New +$2.17M
OKUR
11
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$1.47M 0.5% 886,075 – –
MRKR icon
12
Marker Therapeutics
MRKR
$12M
$1.35M 0.46% 314,286 – –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$1.29M 0.44% 1,009,779 – –
SPRB
14
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$948K 0.32% 1,205,511 – –
ACRS icon
15
Aclaris Therapeutics
ACRS
$209M
$539K 0.18% 434,455 – –
VIRX
16
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$294K 0.1% 288,571 – –
BCEL
17
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– – -387,653 Closed -$51.2K